# Carroucell

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/carroucell

- Industry: Biotechnology
- Headquarters: France
- Website: www.carroucell.com
- Total disclosed funding: $0.8M
- Latest round: Series A (Jun 30, 2022)
- Investors on record: 2

## About

Founded in 2016 by Tarek Fathallah and based in France, Carroucell operates as a biotechnology company that supplies microcarriers for cell culture in bioreactors. In September 2022, Carroucell raised EUR 1.5 million in Series A funding from Novalis Biotech, including Crédit Agricole des Savoie Capital and Bpifrance. As of 2022, Takis Breyiannis is the CEO of the company.

The company provides a technological platform that offers microcarriers with a glass xenofree composition for cell culture in bioreactors. The firm offers a customization service, which is a sol-gel technology that allows for full customization, optimizing shape, weight, size, and composition in order to match cell culture's needs.

The organization plans to use the September 2022 funding to accelerate corporate growth through the industrialization of the company’s platform technology and ramping up of mass production processes to GMP standards.

## Funding rounds

- Series A, Jun 30, 2022, $0.8M — Crédit Agricole des Savoie Capital, Novalis Biotech

## Investors

- Crédit Agricole des Savoie Capital — Series A
- Novalis Biotech (https://capitalatlas.ai/funds/novalis-biotech) — Series A